Does TRT actually cause hair loss, or is genetics doing the work?
Quick answer
TRT raises circulating testosterone, which can increase DHT conversion via 5-alpha reductase, potentially accelerating androgenetic alopecia in genetically predisposed men. The predisposition is androgen receptor sensitivity in hair follicles, largely inherited, making family history the most relevant screening factor before starting therapy. Clinicians managing TRT should proactively discuss hair loss risk alongside other androgen-related side effects, and consider whether adjunct therapies like finasteride are appropriate given the patient's individual risk profile and priorities.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @alphaclubsupps actually say?
The creator's core claim is simple: TRT can accelerate hair loss, but only if you're already genetically wired for it. His exact framing was "if you have a predisposition to male pattern baldness, TRT can be a bit of an issue" and if you don't, "it's not so much of a concern." He then pivoted to a personal cost-benefit argument: at 46 and already thinning, the quality-of-life gains from TRT outweigh worrying about his hair.
That's actually a more nuanced take than most TikTok testosterone content delivers. He's not saying TRT is harmless for everyone. He's not promising you'll keep a full head of hair. He's making a conditional claim tied to genetics, then layering in a personal values statement. Those are two different things, and it's worth separating them.
Does the science back this up?
Mostly, yes. The genetics piece is well-supported. Male pattern baldness, or androgenetic alopecia, is driven by dihydrotestosterone (DHT), a metabolite of testosterone converted by the enzyme 5-alpha reductase. Men with androgen receptor sensitivity in hair follicles, largely a genetic trait, lose hair faster when DHT rises. Raising testosterone through TRT increases the substrate available for DHT conversion.
Randall (2008, Journal of Endocrinology) summarized the androgen-hair follicle relationship clearly: follicle sensitivity to androgens is genetically programmed, and that sensitivity, not circulating androgen levels alone, determines hair loss trajectory. Trüeb (2002, Experimental Gerontology) confirmed that men without the genetic predisposition do not reliably develop androgenetic alopecia even with elevated androgens.
The "not so much of a concern" qualifier for non-predisposed men holds up in the literature. But it's not zero risk, and the creator glosses over that distinction.
What did they get wrong (or right)?
He got the genetics-dependent mechanism right. That's the honest answer to the question, and most influencers dodge it entirely.
What he underplays: the predisposition is more common than people realize. Androgenetic alopecia affects roughly 50% of men by age 50, according to Norwood (1975, Archives of Dermatology), a figure that's held across multiple population studies. So "I probably don't have the predisposition" is actually a coin flip for a lot of his audience, not a safe assumption.
He also doesn't mention that TRT can accelerate the timeline even in men who would have eventually lost hair anyway, not just confirm a fate. If you were going to start thinning at 55, supraphysiologic or high-normal testosterone levels could move that to 40. That's a meaningful distinction for a younger audience.
The cost-benefit framing at the end is a personal opinion, not a medical claim. That's fine. But presenting it as a universal "is it that much of a concern" dismisses a legitimate side effect some men care deeply about.
What should you actually know?
If hair loss is a concern for you and you're considering TRT, there are things worth understanding before you start.
- DHT is the actual driver. Testosterone itself has a weaker androgenic effect on follicles than DHT. If you're predisposed, the enzyme 5-alpha reductase activity in your scalp is what matters most.
- Finasteride is sometimes co-prescribed with TRT to block 5-alpha reductase conversion and reduce DHT. This has its own side effect profile, including potential sexual side effects, that requires a real clinical conversation, not a TikTok comment.
- Not all testosterone formulations raise DHT equally. Topical gels applied to the skin tend to produce higher DHT levels relative to injections, because skin contains high concentrations of 5-alpha reductase. Testosterone cypionate injections typically produce more moderate DHT elevations. Zitzmann et al. (2001, Journal of Clinical Endocrinology and Metabolism) documented these formulation-dependent differences.
- Family history is the single best predictor, but it's not a guarantee in either direction. Your maternal grandfather's hairline is relevant data. So is your paternal grandfather's.
- If you're already on TRT and noticing accelerated shedding, that's a clinical signal worth raising with your prescriber, not just accepting.
The creator's personal calculation, that feeling well and performing well is worth more than hair, is a legitimate individual choice. But that tradeoff belongs in a conversation with a clinician who knows your labs and your history, not a 30-second clip.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Does TRT actually cause hair loss, or is genetics doing the work?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Does TRT actually cause hair loss, or is genetics doing the work? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
TRT raises circulating testosterone, which can increase DHT conversion via 5-alpha reductase, potentially accelerating androgenetic alopecia in genetically predisposed men.
FormBlends verdict
TRT raises circulating testosterone, which can increase DHT conversion via 5-alpha reductase, potentially accelerating androgenetic alopecia in genetically predisposed men. The predisposition is androgen receptor sensitivity in hair follicles, largely inherited, making family history the most relevant screening factor before starting therapy. Clinicians managing TRT should proactively discuss hair loss risk alongside other androgen-related side effects, and consider whether adjunct therapies like finasteride are appropriate given the patient's individual risk profile and priorities.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- TRT raises circulating testosterone, which can increase DHT conversion via 5-alpha reductase, potentially accelerating androgenetic alopecia in genetically predisposed men. The predisposition is androgen receptor sensitivity in hair follicles, largely inherited, making family history the most relevant screening factor before starting therapy. Clinicians managing TRT should proactively discuss hair loss risk alongside other androgen-related side effects, and consider whether adjunct therapies like finasteride are appropriate given the patient's individual risk profile and priorities.
- DHT, not testosterone itself, is the primary driver of androgenetic alopecia. TRT raises DHT by increasing substrate for 5-alpha reductase conversion.
- Androgenetic alopecia affects roughly 50% of men by age 50 (Norwood, 1975, Archives of Dermatology), meaning the genetic predisposition is common, not rare.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- DHT, not testosterone itself, is the primary driver of androgenetic alopecia. TRT raises DHT by increasing substrate for 5-alpha reductase conversion.
- Androgenetic alopecia affects roughly 50% of men by age 50 (Norwood, 1975, Archives of Dermatology), meaning the genetic predisposition is common, not rare.
- Topical testosterone gels produce higher DHT elevations than injections due to high 5-alpha reductase activity in skin, per Zitzmann et al. (2001, Journal of Clinical Endocrinology and Metabolism). Formulation choice matters.
- TRT can accelerate the timeline of hair loss in predisposed men, not just confirm an inevitable outcome. Starting to thin at 40 instead of 55 is a real possibility for some patients.
- Finasteride blocks 5-alpha reductase and reduces DHT, and is sometimes co-prescribed with TRT to mitigate hair loss. It carries its own side effect profile and requires clinical evaluation.
- Family history, particularly maternal and paternal grandfathers, remains the most accessible predictor of androgenetic alopecia risk before starting TRT.
- The creator's cost-benefit framing is a personal opinion, not a clinical recommendation. Anyone concerned about hair loss on TRT should raise it directly with their prescriber.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Alpha Club Supplements UK · TikTok creator
4.1K views on this video
Replying to @HARBER Can TRT cause hair loss? Short answer… yes, it can 👇 If you’ve got a genetic predisposition to male pattern baldness (runs in the family), increasing androgens can speed up what was already coming. If you don’t have that predisposition? It’s far less of a concern. That’s the honest answer. But let’s be real for a second… I’m 46. Hair’s thinning a bit. Is it TRT? Probably not. It’s just life. So what do I do? Buzz it. Move on. Crack on. Why would you let your hairl
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Alpha Club Supplements UK, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.